NASDAQ : YDES
YD Bio Limited — Financial statements
Healthcare · Biotechnology · Taiwan
Last price 5.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 420.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
YD Bio Limited (YDES) reported revenue of 1.24M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 1.24M | 596.82K | 510.36K | 350.13K | 364.12K |
| Cost of Revenue | 872.47K | 429.41K | 355.00K | 196.69K | 230.94K |
| Gross Profit | 366.85K | 167.41K | 155.36K | 153.44K | 133.18K |
| Selling, General & Admin | 4.99M | 3.83M | 1.13M | 160.56K | 180.78K |
| Research & Development | 1.92M | 1.60M | 491.35K | ||
| Operating Expenses | 6.92M | 5.44M | 1.62M | 163.29K | 178.09K |
| Operating Income | -6.55M | -5.27M | -1.46M | -9.85K | -44.91K |
| Interest Expense | -772.00 | -2.14K | -3.18K | ||
| Interest & Investment Income | 114.43K | 80.16K | 11.81K | 290.00 | 96.00 |
| Other Non Operating Income (Expenses) | 6.74M | -3.12M | 64.42K | 29.35K | 55.97K |
| EBT Excluding Unusual Items | 305.74K | -8.31M | -1.39M | 17.65K | 7.98K |
| Gain (Loss) on Sale of Investments | -56.39K | ||||
| Pretax Income | 305.74K | -8.31M | -1.39M | 17.65K | -48.41K |
| Income Tax Expense | -24.00 | -1.53K | 25.08K | 4.09K | 2.37K |
| Net Income | 305.76K | -8.31M | -1.41M | 13.56K | -50.78K |
| Net Income to Common | 305.76K | -8.31M | -1.41M | 13.56K | -50.78K |
| Shares Outstanding (Basic) | 69.77M | 66.72M | 64.73M | 64.73M | |
| Shares Outstanding (Diluted) | 69.77M | 66.72M | 64.73M | 64.73M | |
| EPS (Basic) | 0.00 | -0.12 | -0.02 | 0.00 | |
| EPS (Diluted) | 0.00 | -0.12 | -0.02 | 0.00 | |
| Free Cash Flow | -8.70M | -8.04M | -1.30M | -55.95K | 69.95K |
| Free Cash Flow Per Share | -0.12 | -0.12 | -0.02 | -0.00 | |
| Gross Margin | 29.60% | 28.05% | 30.44% | 43.82% | 36.58% |
| Operating Margin | -528.73% | -883.31% | -286.45% | -2.81% | -12.33% |
| Profit Margin | 24.67% | -1,392.61% | -276.58% | 3.87% | -13.95% |
| Free Cash Flow Margin | -702.15% | -1,346.60% | -254.25% | -15.98% | 19.21% |
| EBITDA | -6.34M | -5.06M | -1.36M | -7.39K | -41.27K |
| EBITDA Margin | -265.93% | -2.11% | -11.34% | ||
| D&A For EBITDA | 210.60K | 209.56K | 104.73K | 2.45K | 3.63K |
| EBIT | -6.55M | -5.27M | -1.46M | -9.85K | -44.91K |
| EBIT Margin | -286.45% | -2.81% | -12.33% | ||
| Effective Tax Rate | 23.17% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.66M | 6.01M | 3.13M | 87.10K | 30.14K |
| Cash & Short-Term Investments | 2.66M | 6.01M | 3.13M | 87.10K | 30.14K |
| Accounts Receivable | 223.07K | 167.48K | 103.51K | 98.17K | 36.58K |
| Other Receivables | 253.25K | 159.29K | 267.00 | 955.00 | |
| Receivables | 223.07K | 420.72K | 262.80K | 98.43K | 37.53K |
| Inventory | 1.89M | 1.88M | 37.34K | 69.40K | 38.67K |
| Prepaid Expenses | 813.95K | 1.32M | 30.26K | 1.99K | 2.47K |
| Other Current Assets | 43.15K | 5.19K | 14.80K | 18.56K | |
| Total Current Assets | 5.59M | 9.67M | 3.47M | 271.72K | 127.37K |
| Property, Plant & Equipment | 57.33K | 67.81K | 88.08K | 14.30K | 59.95K |
| Long-Term Investments | 10.62K | 10.65K | |||
| Other Intangible Assets | 2.47M | 2.61M | 2.68M | ||
| Long-Term Deferred Tax Assets | 24.57K | 28.78K | |||
| Long-Term Deferred Charges | 628.23K | ||||
| Other Long-Term Assets | 1.94M | 1.43M | |||
| Total Assets | 10.06M | 13.78M | 6.86M | 321.21K | 226.76K |
| Accounts Payable | 371.59K | 763.69K | 26.87K | 17.98K | 12.57K |
| Accrued Expenses | 333.41K | 838.71K | 219.45K | 15.07K | 10.80K |
| Current Portion of Long-Term Debt | 34.32K | 32.36K | |||
| Current Portion of Leases | 5.00K | 6.76K | 16.58K | 13.26K | 44.54K |
| Other Current Liabilities | 358.86K | 34.41K | 167.00 | 217.59K | 69.94K |
| Total Current Liabilities | 1.07M | 1.64M | 263.06K | 298.22K | 170.21K |
| Long-Term Debt | 35.09K | ||||
| Long-Term Leases | 5.68K | 12.13K | |||
| Long-Term Deferred Tax Liabilities | 1.46K | ||||
| Other Long-Term Liabilities | 4.52M | 14.99M | 3.77K | ||
| Total Liabilities | 5.59M | 16.64M | 273.98K | 298.22K | 217.42K |
| Common Stock | 7.08K | 7.08K | 6.47K | 105.20K | 105.20K |
| Additional Paid-In Capital | 7.86M | 7.16M | 8.47M | 386.07K | 386.07K |
| Retained Earnings | -3.54M | -10.24M | -1.93M | -515.48K | -529.04K |
| Comprehensive Income & Other | 142.32K | 213.94K | 45.07K | 47.21K | 47.11K |
| Shareholders' Equity | 4.47M | -2.86M | 6.59M | 22.99K | 9.34K |
| Total Liabilities & Equity | 10.06M | 13.78M | 6.86M | 321.21K | 226.76K |
| Total Debt | 5.00K | 6.76K | 22.27K | 47.58K | 124.11K |
| Net Cash (Debt) | 2.66M | 6.00M | 3.11M | 39.52K | -93.97K |
| Net Cash Per Share | 0.04 | 0.09 | 0.05 | 0.00 | |
| Filing Date Shares Outstanding | 70.84M | 70.83M | 1.44M | 1.05M | |
| Total Common Shares Outstanding | 70.84M | 70.79M | 1.44M | 1.05M | |
| Working Capital | 4.52M | 8.03M | 3.20M | -26.49K | -42.83K |
| Book Value Per Share | 0.06 | -0.04 | 4.57 | 0.02 | |
| Tangible Book Value | 2.00M | -5.47M | 3.91M | 22.99K | 9.34K |
| Tangible Book Value Per Share | 0.03 | -0.08 | 2.71 | 0.02 | |
| Machinery | 87.92K | 81.81K | 9.14K | 37.45K | |
| Leasehold Improvements | 47.78K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | 305.76K | -8.31M | -1.41M | 13.56K | -50.78K |
| Depreciation & Amortization | 210.60K | 209.56K | 104.73K | 2.45K | 3.63K |
| Loss (Gain) From Sale of Assets | 4.04K | 109.00 | 466.00 | ||
| Loss (Gain) From Sale of Investments | 56.39K | ||||
| Provision & Write-off of Bad Debts | 3.85K | 3.40K | -493.00 | 2.73K | -2.68K |
| Other Operating Activities | -6.67M | 3.19M | 38.31K | 51.83K | 61.88K |
| Change in Accounts Receivable | -409.13K | -358.91K | -11.02K | -63.86K | 99.23K |
| Change in Inventory | -1.52M | -1.84M | 28.52K | -30.57K | -2.61K |
| Change in Accounts Payable | 335.42K | 386.42K | 10.20K | 5.39K | -12.18K |
| Change in Other Net Operating Assets | 422.13K | 129.13K | 18.64K | -37.66K | -82.92K |
| Operating Cash Flow | -7.26M | -6.60M | -1.22M | -55.66K | 69.95K |
| Capital Expenditures | -1.45M | -1.44M | -74.91K | -290.00 | |
| Sale (Purchase) of Intangibles | -2.84M | ||||
| Investment in Securities | 10.32K | -67.40K | |||
| Investing Cash Flow | -1.95M | -1.44M | -2.90M | -290.00 | -67.40K |
| Short-Term Debt Issued | 314.41K | 146.50K | 8.09K | ||
| Total Debt Issued | 314.41K | 146.50K | 8.09K | ||
| Short-Term Debt Repaid | -99.56K | -46.63K | |||
| Long-Term Debt Repaid | -32.98K | -32.61K | -33.30K | ||
| Total Debt Repaid | -132.53K | -32.61K | -79.93K | ||
| Net Debt Issued (Repaid) | 181.87K | 113.89K | -71.84K | ||
| Issuance of Common Stock | 13.93M | 13.92M | 7.55M | ||
| Other Financing Activities | -2.49M | -3.05M | -614.14K | ||
| Financing Cash Flow | 11.45M | 10.87M | 7.11M | 113.89K | -71.84K |
| Foreign Exchange Rate Adjustments | -47.04K | 42.89K | 55.04K | -984.00 | -7.08K |
| Net Cash Flow | 2.19M | 2.88M | 3.05M | 56.96K | -76.38K |
| Free Cash Flow | -8.70M | -8.04M | -1.30M | -55.95K | 69.95K |
| Free Cash Flow Margin | -702.15% | -1,346.60% | -254.25% | -15.98% | 19.21% |
| Free Cash Flow Per Share | -0.12 | -0.12 | -0.02 | -0.00 | |
| Levered Free Cash Flow | -6.46M | -3.88M | 64.60K | ||
| Unlevered Free Cash Flow | -6.46M | -3.88M | 65.94K | ||
| Cash Interest Paid | 3.18K | ||||
| Change in Working Capital | -1.17M | -1.69M | 46.33K | -126.70K | 1.51K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 420.74M | 857.20M | 45.38M | 47.42M | 50.38M |
| Enterprise Value | 418.08M | 854.09M | 42.66M | ||
| Last Close Price | 5.94 | 12.19 | 11.25 | 11.03 | 10.43 |
| PE Ratio | 1,355.55 | 3,497.12 | |||
| PS Ratio | 339.49 | 1,436.28 | 88.92 | 135.44 | 138.36 |
| PB Ratio | 94.06 | -300.18 | 6.89 | 2,062.32 | 5,396.83 |
| P/TBV Ratio | 210.34 | 11.61 | 2,062.32 | 5,396.83 | |
| P/FCF Ratio | 720.26 | ||||
| P/OCF Ratio | 720.26 | ||||
| EV/Sales Ratio | 337.35 | 1,431.07 | 83.59 | ||
| Debt / Equity Ratio | 0.00 | -0.00 | 0.00 | 2.07 | 13.29 |
| Debt / EBITDA Ratio | 1.18 | 6.81 | |||
| Debt / FCF Ratio | 1.77 | ||||
| Net Debt / Equity Ratio | -0.59 | 2.10 | -0.47 | -1.72 | 10.07 |
| Net Debt / EBITDA Ratio | 0.42 | 1.19 | 2.29 | 5.34 | -2.28 |
| Net Debt / FCF Ratio | 0.30 | 0.75 | 2.40 | 0.71 | 1.34 |
| Asset Turnover | 0.06 | 0.14 | 1.28 | ||
| Inventory Turnover | 0.45 | 6.65 | 3.64 | ||
| Quick Ratio | 2.70 | 3.91 | 12.91 | 0.62 | 0.40 |
| Current Ratio | 5.23 | 5.88 | 13.18 | 0.91 | 0.75 |
| Return on Equity (ROE) | -445.10% | -42.69% | 83.89% | ||
| Return on Assets (ROA) | -31.92% | -25.43% | -2.25% | ||
| Return on Invested Capital (ROIC) | -360.63% | -67.52% | -42.01% | -43.47% | |
| Return on Capital Employed (ROCE) | -72.90% | -43.40% | -22.10% | -42.80% | -79.40% |
| Earnings Yield | 0.07% | -0.97% | -3.11% | 0.03% | -0.10% |
| FCF Yield | -2.07% | -0.94% | -2.86% | -0.12% | 0.14% |
| Buyback Yield / Dilution | 13.49% | -3.07% |